Moneycontrol PRO
HomeNewsBusinessStocksTorrent Pharmaceuticals shares rise 2% on Nifty Next 50

Torrent Pharmaceuticals shares rise 2% on Nifty Next 50

With the stock's last traded price at Rs 3,529.70, Torrent Pharmaceuticals has seen a gain of 2.03 percent in today's session.

July 17, 2025 / 11:40 IST
Disclaimer This is an AI-assisted live blog with updates from multiple sources Disclaimer
Torrent Pharma shares gain in trade
     
     
    26 Aug, 2025 12:21
    Volume
    Todays L/H
    More

    Shares of Torrent Pharmaceuticals gained 2% in Thursday's session. The stock showcased positive movement. Torrent Pharmaceuticals is included as one of the stocks in the NIFTY NEXT 50 index.

    Financial Highlights:

    Torrent Pharmaceuticals' financial performance reveals the following:

    The consolidated quarterly revenue for March 2025 stood at Rs 2,959 Crore, compared to Rs 2,745 Crore in March 2024. The net profit for the same period was Rs 498 Crore, slightly up from Rs 449 Crore year-on-year. The EPS stood at Rs 14.71 in March 2025 compared to Rs 13.27 in March 2024.

    The consolidated yearly revenue for March 2025 was Rs 11,516.09 Crore, a rise from Rs 10,727.84 Crore in March 2024. Net profit for the year stood at Rs 1,911.25 Crore, up from Rs 1,656.38 Crore in the previous year. The EPS increased to Rs 56.47 in March 2025 from Rs 48.94 in March 2024.

    Key financial ratios include a debt-to-equity ratio of 0.40 as of March 2025. The P/E ratio stood at 57.16, and the P/B ratio was 14.42.

    The following tables provide a detailed overview of Torrent Pharmaceuticals' financial performance:

    Revenue (Rs. Crore)Mar 2025Mar 2024Sep 2024Jun 2024Mar 2024
    Consolidated Quarterly2,959.002,809.002,889.002,859.002,745.00

    The quarterly revenue has increased by 7.79 percent from Mar 2024 to Mar 2025.
    Net Profit (Rs. Crore)Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
    Consolidated Quarterly498.00503.00453.00457.00449.00

    The quarterly net profit has increased by 10.91 percent from Mar 2024 to Mar 2025.
    EPSMar 2025Dec 2024Sep 2024Jun 2024Mar 2024
    Consolidated Quarterly14.7114.8813.3713.5113.27

    The quarterly EPS has increased by 10.85 percent from Mar 2024 to Mar 2025.
    Revenue (Rs. Crore)20252024202320222021
    Consolidated Yearly11,516.0910,727.849,620.158,508.048,004.57

    The yearly revenue has increased by 7.35 percent from 2024 to 2025.
    Net Profit (Rs. Crore)20252024202320222021
    Consolidated Yearly1,911.251,656.381,245.23777.181,251.88

    The yearly net profit has increased by 15.39 percent from 2024 to 2025.
    EPS20252024202320222021
    Consolidated Yearly56.4748.9436.7945.9373.98

    The yearly EPS has increased by 15.39 percent from 2024 to 2025.

    Corporate Actions:

    The company announced a final dividend of Rs 6 per share (120%) with an effective date of June 20, 2025. Additionally, an interim dividend of Rs 26 per share (520%) was announced on January 14, 2025, with an effective date of January 31, 2025.

    Torrent Pharmaceuticals had earlier announced a stock split, with the old face value of Rs 10 being split to a new face value of Rs 5. The ex-split date for this corporate action was February 20, 2006.

    With the stock's last traded price at Rs 3,529.70, Torrent Pharmaceuticals has seen a gain of 2.03 percent in today's session.

    Alpha Desk
    first published: Jul 17, 2025 11:40 am

    Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

    Subscribe to Tech Newsletters

    • On Saturdays

      Find the best of Al News in one place, specially curated for you every weekend.

    • Daily-Weekdays

      Stay on top of the latest tech trends and biggest startup news.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347